Selank hmoov

Selank hmoov
Paub meej:
CAS Nr .: 129954-34-3
Qhov tsos: Dawb hmoov
MF: C33H57N11O9
wb: 751.87
Specifications: Raw hmoov los yog vials daim ntawv
Purity: NLT 99.63%
Solubility: Yooj yim soluble hauv dej
Amino acid sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
Customization Service: Negotiable; daim ntawv lo, vials loj, thiab mg rau ib lub vial tuaj yeem kho tau. Tab sis peb tsuas yog lees txais kev txiav txim rau kev tshawb fawb.
Xa kev nug
Hauj lwm lawm
Xa kev nug

Selankhmoovyog ib qho hluavtaws heptapeptide muab tau los ntawm lub cev tiv thaiv kab mob peptide tuftsin (ib ntus: Thr-Lys-Pro-}Arg-Pro-Gly-Pro; abbreviated li TKPRPGP). Nyob rau sab hnub tuaj Europe thiab Lavxias teb sab- thaj chaw hais lus, nws tau kawm dav dav rau nws txoj kev ntxhov siab thiab kev ntxhov siab- tswj cov ntawv thov. Nws yog feem ntau muaj raws li lyophilized hmoov formulation rau kev npaj ntxiv rau hauv cov tshuaj tsuag qhov ntswg los yog txhaj tshuaj. Nws raug suav hais tias muaj kev ntxhov siab me me, kev ntxhov siab- kho dua tshiab, thiab kev txawj ntse- cov txiaj ntsig txhawb nqa, nrog kev pheej hmoo tsawg dua sedative thiab kev vam meej dua li benzodiazepines.

Raws li ib qho ntawm Tuam Tshoj tus sab saum toj xya peptide lwm tus neeg, Shaanxi Medibridge muab selank nrog ib tug purity ntawm 99.63%. Cov txheej txheem kev lag luam yog kwv yees li 97%, thiab qee qhov me me, tsis yog -labs ua raws li txawm tias poob qis dua 95%. Kev xaiv peb txhais tau tias muaj kev coj dawb huv siab dua, cov lus qhia nruj dua, thiab cov txiaj ntsig zoo sib xws.

Selank powder

 

 

COA

 

product-833-138

Khoom npe

CAS Nr

Batch Number

Selank

129954-34-3

MB2507190658

Hnub tim tsim khoom

Hnub Soj Ntsuam

Hnub Kawg

2025-06-20

2025-06-21

2027-06-19

Qauv Qty Base

Ntim

Txoj Kev Xeem

37.62 KWG

100GS / lub raj mis

HPLC

 

Yam khoom

Txuj

Cov txiaj ntsig

Purity

Ntau dua lossis sib npaug li 98%

99.53%

Peptide Assay

Ntau dua lossis sib npaug li 80%

90.11%

Loj Spectrum

751.87

751.87

Solubility

Soluble hauv dej

Ua raws

Clarity thiab xim ntawm kev daws

Ntshiab thiab tsis muaj xim

Ua raws

Sodium ntsev

<5.0%

1.52%

Dej

Tsawg dua lossis sib npaug li 5.0%

1.92%

Residual Solvent:

Methanol

 

Tsawg dua lossis sib npaug li 0.3%

0.0072%

Isopropanol

Tsawg dua los yog sib npaug li 0.5%

N.D.

Cov tshuaj acetonitrile

Tsawg dua lossis sib npaug li 0.041%

0.009%

Methylene Chloride

Tsawg dua lossis sib npaug li 0.06%

0.027%

N,N{0}}Dimethylformamide

Tsawg dua lossis sib npaug li 0.088%

Ua raws

Triethylamine

Tsawg dua lossis sib npaug li 0.032%

Ua raws

Tert -butyl methyl ether

Tsawg dua los yog sib npaug li 0.5%

0.157%

Endotoxin

Tsawg dua lossis sib npaug li 0.5 EU / mg

Ua raws

Microbial txwv

Tag nrho cov kab mob aerobic<100 CFU/g

Tag nrho cov poov xab & pwm<50 CFU/g

<50 CFU/g

<10 CFU/g

Cia

Khaws rau hauv qhov chaw tsaus thiab txias qhuav (-20 txog 8 degree)

Xaus

Cov batch ua raws li IN-HOUSE tus qauv

product-907-160

 

 

Specifications (rau kev tshawb fawb siv nkaus xwb)

 

Peb qhov zoo

1. High-purity heptapeptide Selank, ua tiav cov ntaub ntawv, npaj siv.

2. Lyophilized hmoov, ruaj khov thiab tsis yog -hygroscopic, reconstitutes hauv vib nas this.

3. Kev tswj xyuas nruj me ntsis batch-rau-batch sib xws, cov txiaj ntsig rov tsim dua.

4. Ua kom tiav COA + HPLC + LC-MS daim ntawv qhia suav nrog.

5. Ntau yam specifications hauv Tshuag, repackaging thiab customization txhawb.

6. Tsawg endotoxin version muaj rau rhiab hauv vitro thwmsim.

7. Kev txhawb nqa kev tshaj lij, ib qho - nres kev pabcuam rau cov qauv thiab cov txheej txheem.

 

Daim ntawv

Qauv Order

Specification

Cov hmoov nyoos

1 g

Purity yog NLT 99.96%

Vials

10 vials

3ml / 5ml / 7ml / 15ml vials thiab lwm yam.

 

 

Kev ntxhov siab-Ntxhais lus Neurobiology - "Kev ntxhov siab & HPA Axis tshawb fawb"

 

 

Selank peptide

 

Tshawb nrhiav tus nqi

Ua raws li kev tswj hwm kev ntxhov siab ntawm ob sab ntawm kev ntxhov siab-zoo li kev coj cwj pwm thiab kev ntxhov siab axis qhov ntsuas yam tsis tau qhia txog kev cuam tshuam sedation tseem ceeb yog qhov tsim nyog rau kev txheeb xyuas qhov tseeb ntawm "kev ntxhov siab-zoo li cov teebmeem" thiab "kev nyuaj siab homeostasis."

 

Cov qauv siv feem ntau / Paradigms:

a. Kev ntxhov siab / Kev ntxhov siab ntev: Kev ntxhov siab, CUMS, tail ncua kev kawm / yuam ua luam dej (nrog lub hom phiaj tswj lub cev muaj zog)

b. Kev Nyeem Ntawv Tus Cwj Pwm: Ua kom siab hla kev tshawb nrhiav, lub teeb thiab tsaus lub thawv, qhib qhov chaw (lub sijhawm nyob hauv nruab nrab, kev vam meej, kev tshawb nrhiav thiab lub cev muaj zog dissociation)

 

Cov ntsiab lus tseem ceeb

a. Cwj Pwm: Qhib caj npab / lub sij hawm hauv nruab nrab, pib latency, tus naj npawb ntawm cov pob faus, dissociation ntawm lub cev muaj zog kev ua ub no thiab cov ntsuas kev ntxhov siab

b. HPA Axis: CRH / ACTH / corticosterone (los yog cortisol) atherosclerosis thiab post- kev ntxhov siab ncov, rov qab tawm tswv yim tsis zoo

c. Molecules: GAD65/67, GABA-A receptor subunits (1/ 2/ 2), BDNF/TrkB, c-Fos Tam Sim No Early Gene Therapy

 

Kev txiav txim siab tsim

a. Intranasal tus me nyuam yog qhov zoo dua (qhov pib sai, tsis tshua muaj qhov tshwm sim), nrog rau "tsis muaj sedation" tswj (rotary / tailed kinematics)

b. Ntau lub sij hawm cov ntsiab lus (mob, 1 lub lis piam, 2 lub lis piam) thiab kev sib deev stratification raug pom zoo; inverted U-zoo li koob koob-zoo gradient yog pom zoo.

 

Tswj thiab Benchmarks

Tsheb hnyav rauselank hmoov, paub me ntsis anxiolytic-zoo li kev tswj hwm (piv txwv li, buspirone), thiab "sedation cuam tshuam" tswj (tsawg- koob tshuaj BZD) kom sib txawv ntawm cov nyhuv profile.

 

 

Neuro-Immune Crosstalk

Tshawb nrhiav tus nqi

Txhawm rau txheeb xyuas qhov "immune homeostasis" cov yam ntxwv ntawm peptides tau los ntawm cov kab mob tiv thaiv kab mob peptide thiab txhawm rau txheeb xyuas qhov sib txuas ntawm kev sib txuas ntawm neuroinflammation thiab kev coj cwj pwm phenotypes.

 

Hauv vitro / peripheral qauv

a. Cov kab mob tseem ceeb / kab mob: THP-1 macrophages, BV2 microglia, peripheral PBMCs; LPS/Poly I: C kev sib tw

b. Endpoints: IL-6, TNF-, IL-1, IL-10, NF-κB p65 nuclear translocation, phagocytosis/chemotaxis, ROS

Selank supplier

Central paj hlwb theem

a. Microglia/astroglia co- kab lis kev cai, paj hlwb hlais o induction; IF/ICC daim ntawv lo ntawm Iba1, GFAP, Synapsin/PSD-95

b. Kev txheeb xyuas kev sib raug zoo ntawm kev coj tus cwj pwm thiab cov kab mob inflammatory biochemical (txawm tias txo qis lub nra hnyav thiab txo kev ntxhov siab-zoo li tus cwj pwm muaj feem cuam tshuam)

 

Kev xav txog kev tsim qauv

Ob lub sij hawm ua ntu zus: pretreatment thiab co-kev kho mob; siv ntau lub cytokine panels thiab txoj hauv kev inhibitor localization (piv txwv li, NF-κB, MAPK)

Selank

 

 

Intranasal Delivery & Brain Targeting

 

Selank buy

 

Tshawb nrhiav tus nqi

Kev lees paub qhov zoo ntawm "qhov ntswg- txoj hauv kev hauv hlwb" thiab ua kom zoo rau qhov raug thiab kev faib tawm ntawm cov tshuaj tsuag / qhov ntswg tee rau hauv nruab nrab lub paj hlwb; haum rau pawg kws tshuaj / xa khoom.

 

Kev xa khoom thiab kev faib tawm

a. Fluorescent/isotope-labeled peptide taug qab ntawm lub cev -spatial faib ntawm olfactory epithelium → olfactory noob → limbic system; lub paj hlwb thaj tsam/plasma ratio.

b. Kev yees duab ntawm cov tshuaj tsuag plume, particle loj faib (D10 / D50 / D90), thiab deposition faib; mucociliary clearance kinetics.

 

Formulation Variables

a. pH 4.5-6.5, isotonicity (NaCl / glycerol / sorbitol); Cov nplaum me me (piv txwv li, HPMC / chitosan) tuaj yeem xaiv kom ncua sij hawm nyob.

b. Compatibility thiab adsorption kev soj ntsuam ntawm cov khoom ntim / valve twj tso kua mis.

 

Cov ntsiab lus kawg

Intrabrain LC-MS/MS quantification, nasal mucosal histological tolerance, olfactory function testing, in vivo pharmacodynamic correlation.

 

 

Peptide Stability & QC

Tshawb nrhiav tus nqi

Muab lub hauv paus zoo rov tsim dua tshiab thiab khaws cia / hloov pauv cov txheej txheem kev ua haujlwm (SOPs) rau kev tshawb fawb cov haujlwm / hloov pauv, txo cov khoom sib txawv thiab kev pheej hmoo ntawm inactivation.

 

Stability thiab Degradation

a. pH / kub / lub teeb kev nyuaj siab; deamidation, oxidation, thiab peptide daim ntawv cog lus hydrolysis txoj kev qhia; khov -thaw cycles thiab residual noo noo (KF).

b. Kev sib piv ntsev hom (acetate / TFA hloov dua siab tshiab); Secondary drying thiab iav hloov kub (Tg') qhov rais.

 

Analytical Methodology

RP-HPLC txoj kev txhim kho (C18, 214/220 nm, gradient/flow rate/ion pair optimization).

LC-MS molecular ion kev pom zoo thiab metabolite/degradation characterization; qis-cov khoom siv adsorption + rov qab kho.

 

Ntim thiab Compatibility

Kev sib piv ntawm borosilicate iav / qis-adsorption polymers; Kev ntsuam xyuas ntawm extractables thiab leachables los ntawm cov tshuaj tsuag valve lub cev.

Selank powder supplier

 

 

Pharmacokinetics & Bioanalysis

1. Kev Tshawb Fawb Tus Nqi: Sib piv qhov raug, lub hlwb faib, thiab cov metabolism hauv kev sib txawv ntawm kev tswj hwm (intranasal / subcutaneous), kev txhawb nqa cov txheej txheem, thiab kev xaiv ntau npaum li cas.

2. Tsim thiab Endpoints: Tsis yog-compartmental pharmacokinetics (Cmax, Tmax, t1/2, AUC, paj hlwb/ntshav ratio), microdialysis/tissue homogenization

3. Bioanalysis: Stable isotope internal standard, SPE/protein precipitation pretreatment, absolute quantification, thiab LLOQ methodology verification.

Lus Cim Tshwj Xeeb: Peptide qauv adsorption thiab matrix cuam tshuam yog qhov tseem ceeb; nws raug pom zoo los tsim ib qho peb -txheej txheej ntawm "tsawg adsorption ntim + rov qab nkhaus + parallel pawg tswj".

Selank manufacturer

 

 

FAQ

 

Q: Selank hmoov yog dab tsi?

A: Lyophilized peptide (ib ntu TKPRPGP), acetate ntsev; Kev Tshawb Fawb Tsuas Siv (RUO).

Q: Nws ntshiab npaum li cas thiab koj ua pov thawj li cas?

A: Ntau dua lossis sib npaug li 99.6% (HPLC); tus kheej los ntawm LC-MS; COA + HPLC / LC-MS cov phiaj xwm suav nrog txhua qhov ntau.

Q: Yuav ua li cas reconstitute?

A: BAC dej / 0.9% NaCl / acetate buffer (pH 5-6); ntxiv rau ntawm phab ntsa vial, maj mam sib tov; yeem 0.22 μm lim.

Q: Pom zoo concentrations (hauv vitro)?

A: Cov khoom lag luam 1-10 mg / mL; ua hauj lwm ntau yam 0.1-1000 nM (optimize per assay).

Q: Yuav khaws cia li cas?

A: hmoov: -20 degree, qhuav thiab tiv thaiv los ntawm lub teeb. Kev daws: 2-8℃Tsawg dua lossis sib npaug li 10 hnub; aliquot thiab khov ntawm -20℃ntev dua; tsis txhob rov khov-thaw.

Q: Endotoxin/sterility?

A: Kev tshawb fawb-qib los ntawm lub neej ntawd; qis -endotoxin xaiv muaj.

 

Tam sim no,selank hmoovyog cov cuab yeej tshawb fawb muaj zog heev hauv nruab nrab GABAergic signaling thiab kev ntxhov siab-HPA axis neuroendocrine hloov kho. Yog tias koj tab tom nrhiav lub chaw tsim khoom zoo peptide rau lub sijhawm ntev, kev sib koom tes ruaj khov, thov hu rau peb ntawm hi@medibridgeapi.com lossis whatsApp: +44 07548632075.

 

Cim npe nrov: Tuam Tshoj selank hmoov manufacturers, lwm tus neeg, Hoobkas

Xa kev nug